Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.195
Neutral
RSI(14)
26.409
Sell
STOCH(KDJ)(9,3,3)
8.801
Oversold
ATR(14)
0.204
High Vlolatility
CCI(14)
-75.950
Neutral
Williams %R
97.071
Oversold
TRIX(12,20)
-3.969
Sell
StochRSI(14)
0.000
Sell
NewGenIvf Group Ltd
NIVF0.797USD
-0.020-2.49%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
343.36KMarket Cap
0.00P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of NewGenIvf Group Ltd
Currency: USD Updated: 2025-12-24Key Insights
NewGenIvf Group Ltd's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered undervalued, ranking 74/78 in the Healthcare Providers & Services industry.Institutional ownership is low.Over the past month, multiple analysts have rated it as , with the highest price target at 75.00.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
NewGenIvf Group Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
75.000
Target Price
+5036.99%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
NewGenIvf Group Ltd Highlights
StrengthsRisks
NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
Growing
The company is in a growing phase, with the latest annual income totaling USD 5.43M.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Fairly Valued
The company’s latest PE is 0.00, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 5.79K shares, increasing 24.77% quarter-over-quarter.
Financial Health
Currency: USD Updated: 2025-12-24The current financial score of NewGenIvf Group Ltd is 5.95, ranking 66/78 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 1.28M, representing a year-over-year decrease of 12.94%, while its net profit experienced a year-over-year decrease of 84822.54%.
Score
Financials
4.73
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
10.00
Operational Efficiency
2.51
Growth Potential
5.44
Shareholder Returns
7.09
NewGenIvf Group Ltd's Company Valuation
Currency: USD Updated: 2025-12-24The current valuation score of NewGenIvf Group Ltd is 7.62, ranking 28/78 in the Healthcare Providers & Services industry. Its current P/E ratio is 0.00, which is 68700492.86% below the recent high of 961.81 and 17588042.86% above the recent low of -246.23.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 74/78
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-24No earnings forecast score is currently available for NewGenIvf Group Ltd. The Healthcare Providers & Services industry's average is 7.54. The average price target for NewGenIvf Group Ltd is 75.00, with a high of 75.00 and a low of 75.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
No Data
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-24The current price momentum score of NewGenIvf Group Ltd is 1.28, ranking 77/78 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 1.68 and the support level at 0.36, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
0.857
Sell
MA10
0.940
Sell
MA20
1.265
Sell
MA50
2.886
Sell
MA100
6.163
Sell
MA200
44.455
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-24Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2025-12-24The current risk assessment score of NewGenIvf Group Ltd is 1.32, ranking 72/78 in the Healthcare Providers & Services industry. The company's beta value is -0.07. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
-0.07
VaR
--
240-Day Maximum Drawdown
+99.96%
240-Day Volatility
+269.02%
Return
Best Daily Return
60 days
+22.60%
120 days
+22.60%
5 years
--
Worst Daily Return
60 days
-39.26%
120 days
-39.26%
5 years
--
Sharpe Ratio
60 days
-4.96
120 days
-4.30
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+99.96%
3 years
+100.00%
5 years
--
Return-to-Drawdown Ratio
240 days
-1.00
3 years
-0.33
5 years
--
Skewness
240 days
+3.37
3 years
--
5 years
--
Volatility
Realised Volatility
240 days
+269.02%
5 years
--
Standardised True Range
240 days
+4546.33%
5 years
--
Downside Risk-Adjusted Return
120 days
-489.97%
240 days
-489.97%
Maximum Daily Upside Volatility
60 days
+214.51%
Maximum Daily Downside Volatility
60 days
+140.74%
Liquidity
Average Turnover Rate
60 days
+11219.28%
120 days
+26678.87%
5 years
--
Turnover Deviation
20 days
-100.00%
60 days
-100.00%
120 days
-100.00%
Peer Comparison
Healthcare Providers & Services
NewGenIvf Group Ltd
NIVF
3.32 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Chemed Corp
CHE
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lifestance Health Group Inc
LFST
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Natera Inc
NTRA
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
8.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Option Care Health Inc
OPCH
8.27 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of NewGenIvf Group Ltd?
The TradingKey Stock Score provides a comprehensive assessment of NewGenIvf Group Ltd based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of NewGenIvf Group Ltd’s performance and outlook.
How do we generate the financial health score of NewGenIvf Group Ltd?
To generate the financial health score of NewGenIvf Group Ltd, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects NewGenIvf Group Ltd's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of NewGenIvf Group Ltd.
How do we generate the company valuation score of NewGenIvf Group Ltd?
To generate the company valuation score of NewGenIvf Group Ltd, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare NewGenIvf Group Ltd’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of NewGenIvf Group Ltd’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of NewGenIvf Group Ltd.
How do we generate the earnings forecast score of NewGenIvf Group Ltd?
To calculate the earnings forecast score of NewGenIvf Group Ltd, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on NewGenIvf Group Ltd’s future.
How do we generate the price momentum score of NewGenIvf Group Ltd?
When generating the price momentum score for NewGenIvf Group Ltd, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of NewGenIvf Group Ltd’s prices. A higher score indicates a more stable short-term price trend for NewGenIvf Group Ltd.
How do we generate the institutional confidence score of NewGenIvf Group Ltd?
To generate the institutional confidence score of NewGenIvf Group Ltd, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about NewGenIvf Group Ltd’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of NewGenIvf Group Ltd.
How do we generate the risk management score of NewGenIvf Group Ltd?
To assess the risk management score of NewGenIvf Group Ltd, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of NewGenIvf Group Ltd’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of NewGenIvf Group Ltd.
